Share price

€63.00
( 1,61 %)
12/08/2022-11:16

Share price

€63.00
( 1,61 %)
12/08/2022-11:16

2020 HALF YEAR RESULTS

2020 HALF-YEAR RESULTS
A strategy that demonstrates its resilience in the context of a global health crisis

A portfolio under management growing by 7% reaching more than 2.3 billion euros

  • 197[1] M € of assets in own account (+ 3% at constant scope vs. December 31, 2019);
  • € 2,143 million managed on behalf of third parties (+ 8% vs. December 31, 2019) in the form of SCPI[2] and OPCI[3].

Solid financial indicators

  • Recurring EPRA net income per share up by 9% to € 3.65 (€ 3.35 at June 30, 2019);
  • Continuing EPRA ANR (NTA) up by 15% over one year to € 128.2 per share (€ 111.1 as of June 30, 2019);
  • Debt (LTV) kept at a low level at 26% (vs. 28% at 12/31/2019);
  • Substantial liquidity of nearly € 40 million (including a confirmed undrawn credit line).

Read more